Avricore Health (AVCRF) Net Cash Flow (2014 - 2025)

Avricore Health has disclosed Net Cash Flow across 12 years of filings, most recently posting -$436061.7 for Q3 2025.

• In Q3 2025, Net Cash Flow fell 218.03% year-over-year to -$436061.7; the TTM figure through Dec 2025 stood at -$540044.0 (down 167.37% YoY), while the FY2025 annual figure was -$647223.3, down 203.53% from the prior year.
• Net Cash Flow retreated to -$436061.7 in Q3 2025, from -$199507.3 in the prior quarter.
• Over the last five years, Net Cash Flow for AVCRF reached as high as $1.8 million in Q1 2021 and fell as low as -$441164.3 in Q3 2022.
• The 5-year median for Net Cash Flow is -$81345.1 (2023), against an average of $15532.5.
• Annual changes were most pronounced in 2022 — Net Cash Flow tumbled 740.12% — and 2024, when it surged 778.58%.
• A 5-year view of Net Cash Flow shows it stood at -$167766.8 in 2021, then decreased by 9.17% to -$183145.8 in 2022, then jumped by 54.7% to -$82973.1 in 2023, then soared by 545.27% to $369454.5 in 2024, then tumbled by 218.03% to -$436061.7 in 2025.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$436061.7, -$199507.3, and $95524.9 for Q3 2025, Q2 2025, and Q1 2025 respectively.